(Q34584724)

3 August 2017

1 reference

title

Randomized clinical trials in gastric cancer. (English)

1 reference

3 August 2017

Sharon M Weber

1

1 reference

PubMed ID

11928796

3 August 2017

Martin S Karpeh

series ordinal

2

1 reference

3 August 2017

1 January 2002

1 reference

Surgical oncology clinics of North America

3 August 2017

1 reference

3 August 2017

11

1 reference

3 August 2017

1

1 reference

3 August 2017

111-31, ix

1 reference

Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Extended lymph-node dissection for gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

The concept of locally advanced gastric cancer. Effect of treatment on outcome. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277)

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Randomized study of combination chemotherapy in unresectable gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

High doses of 5-fluorouracil and epirubicin with or without cisplatin in advanced gastric cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900077-2

7 January 2021

10.1016/S1055-3207(03)00077-2

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11928796